Mc2 Drug Patent Portfolio
Mc2 owns 1 orange book drug protected by 4 US patents Given below is the list of Mc2's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11638711 | NULL | 18 Mar, 2039 | Active |
| US11696919 | Topical composition | 18 Mar, 2039 | Active |
| US12440499 | Topical Composition | 18 Mar, 2039 | Active |
| US10265265 | Topical composition | 27 Sep, 2027 | Active |
Latest Legal Activities on Mc2's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Mc2.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Corrected Notice of Allowability | 11 Sep, 2025 | US12440499 |
| Pubs Case Remand to TC | 08 Sep, 2025 | US12440499 |
| Mail Notice of Allowance | 04 Sep, 2025 | US12440499 |
| Notice of Allowance Data Verification Completed | 03 Sep, 2025 | US12440499 |
| Interview Summary - Examiner Initiated - Telephonic | 21 Aug, 2025 | US12440499 |
| Date Forwarded to Examiner | 25 Jul, 2025 | US12440499 |
| Response after Final Action | 22 Jul, 2025 | US12440499 |
| Request for Extension of Time - Granted | 22 Jul, 2025 | US12440499 |
| Email Notification | 14 Jul, 2025 | US12440499 |
| Mail Advisory Action (PTOL - 303) | 14 Jul, 2025 | US12440499 |
| Advisory Action (PTOL-303) | 11 Jul, 2025 | US12440499 |
| PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED | 07 Jul, 2025 | US12440499 |
| Terminal Disclaimer Filed | 02 Jul, 2025 | US12440499 |
| Date Forwarded to Examiner | 10 Jun, 2025 | US12440499 |
| Response after Final Action | 05 Jun, 2025 | US12440499 |
Mc2's Family Patents
Mc2 Drug List
Given below is the complete list of Mc2's drugs and the patents protecting them.
1. Wynzora
Wynzora is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11638711 | NULL |
18 Mar, 2039
(13 years from now)
| Active |
| US11696919 | Topical composition |
18 Mar, 2039
(13 years from now)
| Active |
| US12440499 | Topical Composition |
18 Mar, 2039
(13 years from now)
| Active |
| US10265265 | Topical composition |
27 Sep, 2027
(1 year, 6 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Wynzora's drug page